½ÃÀ庸°í¼­
»óǰÄÚµå
1589835

¼¼°èÀÇ Ã¼¿Ü Ãæ°ÝÆÄ ¼â¼®¼ú ½ÃÀå : ±â¼ú, Ä¡·á, ÃÖÁ¾ ¿ëµµº° ¿¹Ãø(2025-2030³â)

Extracorporeal Shock Wave Lithotripsy Market by Technology (Electrohydraulic Technique, Electromagnetic Technique, Piezoelectric Technique), Treatment (Bladder Calculi, Uretric & Renal Stones), End Use - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 194 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ü¿Ü Ãæ°ÝÆÄ ¼â¼®¼ú ½ÃÀåÀº 2023³â 3¾ï 4,009¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 3¾ï 6,048¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 6.39%·Î ¼ºÀåÇØ 2030³â¿¡´Â 5¾ï 2,475¸¸ ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ü¿Ü Ãæ°ÝÆÄ ¼â¼®¼ú(ESWL)Àº ½ÅÀå °á¼®°ú ƯÁ¤ ´ã¼®ÀÇ Ä¡·á¿¡ »ç¿ëµÇ´Â ºñ ħ½ÀÀû ÀÎ ÀÇ·á ÀýÂ÷ÀÔ´Ï´Ù. ESWLÀº ¿ÜºÎ¿¡¼­ Ãæ°ÝÆÄ¸¦ Á¶»çÇÏ¿© °á¼®À» ¹Ì¼¼ÇÏ°Ô ºÎ¼ö°í ¿ä·Î¸¦ Åë°úÇϱ⠽±½À´Ï´Ù. ESWLÀº ³·Àº ħ½À¼º, ȸº¹ ½Ã°£ ´ÜÃà, º¸´Ù ħ½ÀÀû ÀÎ ¼ö¼ú Ä¡·áÀÇ Çʿ伺À» ÁÙÀ̱â À§ÇØ ÇÊ¿äÇϸç ȯÀÚ ¹× °Ç°­ °ü¸® Á¦°ø¾÷ü¿¡°Ô ¼±È£µÇ´Â ¼±ÅÃÀÔ´Ï´Ù. ÀÌ ÀýÂ÷´Â ÁÖ·Î ºñ´¢±â°ú ºÐ¾ß¿¡¼­ ÀÀ¿ëµÇ¸ç ¼®È¸ Ä§Âø¼º °ß°Ç¿°°ú °°Àº Áõ»ó Ä¡·á¿¡µµ À¯¿ëÇÒ °ÍÀ¸·Î ±â´ëµË´Ï´Ù. ÃÖÁ¾ ¿ëµµ¿¡´Â º´¿ø, Ŭ¸®´Ð, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC) µîÀÌ Æ÷ÇԵ˴ϴÙ. ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº ¿ä·Î °á¼®ÁõÀÇ À¯º´·ü »ó½Â, ESWL ±â¼úÀÇ Áøº¸, ºñħ½ÀÀû Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡ÀÔ´Ï´Ù. ¶ÇÇÑ, °á¼®À» Çü¼ºÇϱ⠽¬¿î Àα¸ÀÇ °í·ÉÈ­, ÇコÄɾî ÁöÃâ Áõ°¡, À¯¸®ÇÑ »óȯ ½Ã³ª¸®¿À µîÀÇ ¿äÀεµ ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 3¾ï 4,009¸¸ ´Þ·¯
¿¹Ãø³â(2024) 3¾ï 6,048¸¸ ´Þ·¯
¿¹Ãø³â(2030) 5¾ï 2,475¸¸ ´Þ·¯
CAGR(%) 6.39%

»õ·Î¿î ºñÁî´Ï½º ±âȸ´Â ÈÞ´ë °¡´ÉÇÏ°í ºñ¿ë È¿À²ÀûÀÎ Àåºñ °³¹ß, 3D ¸ÅÇÎ ¹× ÀÚµ¿È­¿Í °°Àº ±â¼ú Çõ½ÅÀ» ÅëÇÑ Á¤È®¼º°ú ¼º°ø·ü Çâ»ó¿¡ ÀÖ½À´Ï´Ù. ÀÇ·á ÀÎÇÁ¶ó °³¼± ¹× ½ÅÀå °á¼® Áõ°¡·Î ±â¾÷Àº ¾Æ½Ã¾ÆÅÂÆò¾ç°ú ¶óƾ¾Æ¸Þ¸®Ä« ½ÃÀå È®´ë¸¦ Ȱ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·³¿¡µµ ºÒ±¸Çϰí Á¶Á÷ ¼Õ»ó°ú °°Àº ÀáÀçÀû ºÎÀÛ¿ë, °æ°ú °üÂûÀÇ Çʿ伺, ´ëü °á¼® Á¦°Å Ä¡·áÀÇ °¡¿ë¼º µîÀÇ Á¦¾àÀÌ ¼ºÀåÀÇ °úÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù. ±ÔÁ¦»óÀÇ Àå¾Ö¹°°ú Ãʱ⠺ñ¿ëÀÇ ³ôÀ̵µ À庮ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÅëÁõ °ü¸® ÇÁ·ÎÅäÄÝÀÇ Çõ½Å, ºÎÀÛ¿ë ¿ÏÈ­, ´Ù¾çÇÑ È¯ÀÚÃþ¿¡ ´ëÇÑ ¼³Á¤ ÃÖÀûÈ­´Â ºñÁî´Ï½º ¼ºÀå¿¡ ¿©ÀüÈ÷ ÇʼöÀûÀÔ´Ï´Ù. ½ÃÀå °æÀïÀº Ä¡¿­Çϰí ÁÖ¿ä ±â¾÷µéÀº Â÷º°È­¸¦ À§ÇØ ¿¬±¸ °³¹ß¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á±â°ü°úÀÇ Çù¾÷À» ÃËÁøÇϰí ȯÀÚ Áß½ÉÀÇ Äɾ ÁÖ·ÂÇÔÀ¸·Î½á ½ÃÀå ħÅõ¸¦ ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î ESWL ½ÃÀåÀº ¼ºÀå ±âȸ¸¦ ¸ÂÀÌÇÏÁö¸¸ ±â¾÷Àº µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ±âȸ¸¦ Ȱ¿ëÇϱâ À§ÇØ ±â¼ú Çõ½Å°ú Áö¸®Àû È®Àå¿¡ Àü·«ÀûÀ¸·Î ÅõÀÚÇØ¾ßÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ: ±Þ¼ÓÈ÷ ÁøÈ­Çϴ ü¿Ü Ãæ°ÝÆÄ ¼â¼®¼ú ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ü¿Ü Ãæ°ÝÆÄ ¼â¼®¼ú ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿Àû ÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ðÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû °áÁ¤ Á¤¹ÐÈ­, »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ëÀ̳ª ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¼¼°èÀÇ ¸¸¼ºÁúȯÀÇ ¸¸¿¬
    • Àúħ½À Ä¡·á¿¡ÀÇ °æ»ç
    • Á¦Ç° ½ÂÀÎÀ² »ó½Â
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±â¼úÀû ¹× ¿î¿µ»óÀÇ ¹®Á¦
  • ½ÃÀå ±âȸ
    • ü¿Ü Ãæ°ÝÆÄ ¼â¼®¼ú¿¡ À־ÀÇ ±â¼úÀÇ Áøº¸
    • ÇコÄɾî ÀÎÇÁ¶ó °­È­¸¦ À§ÇÑ Áß¿äÇÑ À̺¥Æ®
  • ½ÃÀåÀÇ °úÁ¦
    • °Ç°­¿¡ ¾Ç¿µÇâ

Porter's Five Forces : ü¿Ü Ãæ°ÝÆÄ ¼â¼®¼ú ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» °áÁ¤ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂûÀ» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ü¿Ü Ãæ°ÝÆÄ ¼â¼®¼ú ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ü¿Ü Ãæ°ÝÆÄ ¼â¼®¼ú ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ü¿Ü Ãæ°ÝÆÄ ¼â¼®¼ú ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

ü¿Ü Ãæ°ÝÆÄ ¼â¼®¼ú ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ü¿Ü Ãæ°ÝÆÄ ¼â¼®¼ú ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ü¿Ü Ãæ°ÝÆÄ ¼â¼®¼ú ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : ü¿Ü Ãæ°ÝÆÄ ¼â¼®¼ú ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ ±æÀ» ±×¸³´Ï´Ù.

ü¿Ü Ãæ°ÝÆÄ ¼â¼®¼ú ½ÃÀåÀÇ Àü·«ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ´É·Â ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¼¼°è¿¡¼­ ¸¸¼ºÁúȯÀÇ ÀÌȯÀ²ÀÌ Áõ°¡
      • Àúħ½À Ä¡·á¿¡ ´ëÇÑ °æÇâ
      • Á¦Ç° ½ÂÀÎÀ² »ó½Â
    • ¾ïÁ¦¿äÀÎ
      • ±â¼úÀû ¹× ¿î¿µ»óÀÇ ¹®Á¦
    • ±âȸ
      • ü¿Ü Ãæ°ÝÆÄ ¼â¼®¼ú¿¡ À־ÀÇ ±â¼úÀû Áøº¸
      • ÇコÄɾî ÀÎÇÁ¶ó¸¦ °­È­ÇÏ´Â Áß¿äÇÑ À̺¥Æ®
    • °úÁ¦
      • °Ç°­¿¡ ¾Ç¿µÇâ
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ü¿Ü Ãæ°ÝÆÄ ¼â¼®¼ú ½ÃÀå : ±â¼úº°

  • Àü±âÀ¯Ã¼ ±â¼ú
  • ÀüÀڱ⠱â¼ú
  • ¾ÐÀü ±â¼ú

Á¦7Àå ü¿Ü Ãæ°ÝÆÄ ¼â¼®¼ú ½ÃÀå : Ä¡·áº°

  • ¹æ±¤°á¼®
  • ¿ä°ü °á¼® ¹× ½Å°á¼®

Á¦8Àå ü¿Ü Ãæ°ÝÆÄ ¼â¼®¼ú ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • Ŭ¸®´Ð
  • º´¿ø

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ Ã¼¿ÜÃæ°ÝÆÄ ¼â¼®¼ú ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ã¼¿Ü Ãæ°ÝÆÄ ¼â¼®¼ú ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Ã¼¿Ü Ãæ°ÝÆÄ ¼â¼®¼ú ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Boston Scientific Corporation
  • Cook Group Incorporated
  • DIREX, SL
  • Dornier MedTech GmbH
  • EDAP TMS SA
  • ELMED Medical Systems
  • KARL STORZ SE & Co. KG
  • Medispec LTD
  • Medtrue Enterprise Co. Ltd.
  • MTS Medical
  • Olympus Corporation
  • Richard-Wolf
  • Sainty Pharma
  • Siemens AG
JHS 24.11.21

The Extracorporeal Shock Wave Lithotripsy Market was valued at USD 340.09 million in 2023, expected to reach USD 360.48 million in 2024, and is projected to grow at a CAGR of 6.39%, to USD 524.75 million by 2030.

Extracorporeal Shock Wave Lithotripsy (ESWL) is a non-invasive medical procedure used to treat kidney stones and certain types of gallstones. It involves delivering shock waves externally to disintegrate stones into smaller fragments for easier passage through the urinary tract. ESWL is necessary due to its minimally invasive nature, reduced recovery time, and reduced need for more invasive surgical procedures, making it a preferred choice for patients and healthcare providers. The procedure finds application primarily in the urology sector, with potential utility in treating conditions like calcific shoulder tendinitis. The end-use scope includes hospitals, clinics, and ambulatory surgical centers. Market growth is driven by the rising prevalence of urolithiasis, advancements in ESWL technology, and growing awareness about non-invasive treatment options. Additional factors include an aging population prone to stone formation, increasing healthcare expenditure, and favorable reimbursement scenarios.

KEY MARKET STATISTICS
Base Year [2023] USD 340.09 million
Estimated Year [2024] USD 360.48 million
Forecast Year [2030] USD 524.75 million
CAGR (%) 6.39%

Emerging opportunities lie in developing portable and cost-effective devices, as well as enhancing precision and success rates through technological innovation like 3D mapping and automation. Companies can leverage expanding markets in Asia-Pacific and Latin America due to improving healthcare infrastructure and rising incidences of kidney stones. Nevertheless, growth is challenged by limitations such as potential adverse effects like tissue damage, the need for follow-up sessions, and availability of alternative stone removal treatments. Regulatory hurdles and high initial costs also pose barriers. Innovating in pain management protocols, reducing side effects, and optimizing settings for varied patient demographics remains essential for business growth. The market exhibits a competitive nature with key players investing in R&D to differentiate their offerings. Fostering collaborations with healthcare institutions and focusing on patient-centered care could enhance market penetration. Overall, the ESWL market is poised for growth, although companies must navigate challenges and invest strategically in innovation and geographical expansion to capitalize on emerging opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Extracorporeal Shock Wave Lithotripsy Market

The Extracorporeal Shock Wave Lithotripsy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of chronic diseases worldwide
    • Inclination towards minimally invasive treatments
    • Rise in product approval rate
  • Market Restraints
    • Technical and operational issues
  • Market Opportunities
    • Technological advancements in extracorporeal shock wave lithotripsy
    • Significant events to enhance healthcare infrastructure
  • Market Challenges
    • Adverse effects on health

Porter's Five Forces: A Strategic Tool for Navigating the Extracorporeal Shock Wave Lithotripsy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Extracorporeal Shock Wave Lithotripsy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Extracorporeal Shock Wave Lithotripsy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Extracorporeal Shock Wave Lithotripsy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Extracorporeal Shock Wave Lithotripsy Market

A detailed market share analysis in the Extracorporeal Shock Wave Lithotripsy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Extracorporeal Shock Wave Lithotripsy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Extracorporeal Shock Wave Lithotripsy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Extracorporeal Shock Wave Lithotripsy Market

A strategic analysis of the Extracorporeal Shock Wave Lithotripsy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Extracorporeal Shock Wave Lithotripsy Market, highlighting leading vendors and their innovative profiles. These include Boston Scientific Corporation, Cook Group Incorporated, DIREX, S.L., Dornier MedTech GmbH, EDAP TMS SA, ELMED Medical Systems, KARL STORZ SE & Co. KG, Medispec LTD, Medtrue Enterprise Co. Ltd., MTS Medical, Olympus Corporation, Richard-Wolf, Sainty Pharma, and Siemens AG.

Market Segmentation & Coverage

This research report categorizes the Extracorporeal Shock Wave Lithotripsy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Electrohydraulic Technique, Electromagnetic Technique, and Piezoelectric Technique.
  • Based on Treatment, market is studied across Bladder Calculi and Uretric & Renal Stones.
  • Based on End Use, market is studied across Clinics and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic diseases worldwide
      • 5.1.1.2. Inclination towards minimally invasive treatments
      • 5.1.1.3. Rise in product approval rate
    • 5.1.2. Restraints
      • 5.1.2.1. Technical and operational issues
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in extracorporeal shock wave lithotripsy
      • 5.1.3.2. Significant events to enhance healthcare infrastructure
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse effects on health
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Extracorporeal Shock Wave Lithotripsy Market, by Technology

  • 6.1. Introduction
  • 6.2. Electrohydraulic Technique
  • 6.3. Electromagnetic Technique
  • 6.4. Piezoelectric Technique

7. Extracorporeal Shock Wave Lithotripsy Market, by Treatment

  • 7.1. Introduction
  • 7.2. Bladder Calculi
  • 7.3. Uretric & Renal Stones

8. Extracorporeal Shock Wave Lithotripsy Market, by End Use

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Hospitals

9. Americas Extracorporeal Shock Wave Lithotripsy Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Extracorporeal Shock Wave Lithotripsy Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Extracorporeal Shock Wave Lithotripsy Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Boston Scientific Corporation
  • 2. Cook Group Incorporated
  • 3. DIREX, S.L.
  • 4. Dornier MedTech GmbH
  • 5. EDAP TMS SA
  • 6. ELMED Medical Systems
  • 7. KARL STORZ SE & Co. KG
  • 8. Medispec LTD
  • 9. Medtrue Enterprise Co. Ltd.
  • 10. MTS Medical
  • 11. Olympus Corporation
  • 12. Richard-Wolf
  • 13. Sainty Pharma
  • 14. Siemens AG
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦